Compare Stocks: AURA, BKY, NEO, and AREC

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AREC American Resources	$2.04 +0.2%	$2.01	$1.14 ▼ $7.11	$217.68M	1.16	3.41 million shs	2.03 million shs
AURA Aura Biosciences	$7.20 +2.3%	$6.93	$4.73 ▼ $9.53	$744.93M	0.4	426,341 shs	81,101 shs
NEO NeoGenomics	$16.08 +1.5%	$12.91	$5.37 ▼ $16.34	$2.07B	1.74	2.34 million shs	917,719 shs

7 Stocks to Buy Before the Robotics Revolution

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AREC American Resources	+13.41%	+15.34%	+3.57%	-11.74%	+72.03%
AURA Aura Biosciences	+0.43%	-1.68%	-9.04%	-20.90%	+4.45%
NEO NeoGenomics	+3.60%	+20.55%	+4.49%	+78.78%	+206.98%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AREC American Resources	$2.04 +0.2%	$2.01	$1.14 ▼ $7.11	$217.68M	1.16	3.41 million shs	2.03 million shs
AURA Aura Biosciences	$7.20 +2.3%	$6.93	$4.73 ▼ $9.53	$744.93M	0.4	426,341 shs	81,101 shs
NEO NeoGenomics	$16.08 +1.5%	$12.91	$5.37 ▼ $16.34	$2.07B	1.74	2.34 million shs	917,719 shs

7 Stocks to Buy Before the Robotics Revolution

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AREC American Resources	+13.41%	+15.34%	+3.57%	-11.74%	+72.03%
AURA Aura Biosciences	+0.43%	-1.68%	-9.04%	-20.90%	+4.45%
NEO NeoGenomics	+3.60%	+20.55%	+4.49%	+78.78%	+206.98%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AREC American Resources	2.60	Moderate Buy	$6.00	194.84% Upside
AURA Aura Biosciences	2.25	Hold	$20.50	184.72% Upside
NEO NeoGenomics	2.73	Moderate Buy	$16.71	3.97% Upside

Current Analyst Ratings Breakdown

Latest AURA, BKY, NEO, and AREC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/31/2026	NEO NeoGenomics	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
7/29/2026	NEO NeoGenomics	Craig Hallum Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$19.00
7/29/2026	NEO NeoGenomics	Needham & Company LLC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$15.00 ➝ $19.00
7/24/2026	NEO NeoGenomics	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$11.00 ➝ $16.00
7/15/2026	NEO NeoGenomics	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
7/14/2026	AURA Aura Biosciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/14/2026	NEO NeoGenomics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/29/2026	AURA Aura Biosciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
6/29/2026	NEO NeoGenomics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
6/12/2026	AURA Aura Biosciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/11/2026	AREC American Resources	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C-) ➝ Sell (D+)

(Data available from 8/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AREC American Resources	$380K	572.85	N/A	N/A	$0.92 per share	2.21
AURA Aura Biosciences	N/A	N/A	N/A	N/A	$2.16 per share	N/A
NEO NeoGenomics	$766.30M	2.70	$0.35 per share	45.64	$6.47 per share	2.48

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AREC American Resources	$55.41M	-$0.41	N/A	2.42	N/A	N/A	N/A	-8.48%	8/19/2026 (Estimated)
AURA Aura Biosciences	-$106.19M	-$1.74	N/A	N/A	N/A	N/A	-78.12%	-64.08%	8/12/2026 (Estimated)
NEO NeoGenomics	-$108.03M	-$0.40	N/A	401.90	N/A	-6.77%	-1.99%	-1.21%	N/A

Latest AURA, BKY, NEO, and AREC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/19/2026	Q1 2026	AREC American Resources	-$0.09	N/A	N/A	N/A	$0.20 million	N/A
8/12/2026	Q2 2026	AURA Aura Biosciences	-$0.41	N/A	N/A	N/A	N/A	N/A
7/28/2026	Q2 2026	NEO NeoGenomics	$0.0336	$0.05	+$0.0165	$0.02	$196.93 million	$201.66 million
5/21/2026	Q1 2026	AURA Aura Biosciences	-$0.40	-$0.50	-$0.10	-$0.50	N/A	N/A
5/19/2026	Q4 2025	AREC American Resources	N/A	$0.75	N/A	$0.75	N/A	($0.10) million
5/11/2026	Q1 2026	AURA Aura Biosciences	-$0.40	-$0.50	-$0.10	-$0.50	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AREC American Resources	N/A	N/A	N/A	N/A	N/A
AURA Aura Biosciences	N/A	N/A	N/A	N/A	N/A
NEO NeoGenomics	N/A	N/A	N/A	N/A	N/A

Latest NEO, AURA, AREC, and NCCL Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/24/2026	AREC American Resources		$0.0431		8/14/2026	8/15/2026	8/25/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AREC American Resources	0.14	2.19	2.19
AURA Aura Biosciences	N/A	7.09	7.09
NEO NeoGenomics	0.48	3.60	3.35

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AREC American Resources	9.32%
AURA Aura Biosciences	96.75%
NEO NeoGenomics	98.50%

Insider Ownership

Company	Insider Ownership
AREC American Resources	1.81%
AURA Aura Biosciences	1.90%
NEO NeoGenomics	1.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AREC American Resources	10	106.97 million	105.04 million	Optionable
AURA Aura Biosciences	50	103.39 million	101.42 million	Not Optionable
NEO NeoGenomics	2,500	128.48 million	127.06 million	Optionable

AURA, BKY, NEO, and AREC Headlines

Recent News About These Companies

NeoGenomics, Inc. (NEO) Hit a 52 Week High, Can the Run Continue?

3 hours ago | zacks.com

NeoGenomics, Inc. $NEO Shares Sold by Glenmede Trust Co. NA

August 4 at 5:19 AM | marketbeat.com

NeoGenomics (NASDAQ:NEO) Reaches New 1-Year High - Here's What Happened

August 4 at 4:39 AM | marketbeat.com

Segall Bryant & Hamill LLC Lowers Holdings in NeoGenomics, Inc. $NEO

August 3 at 5:27 AM | marketbeat.com

Which Is a Better Investment, NeoGenomics, Inc. or GeneDx Holdings Corp. Stock?

August 1 at 8:18 PM | aaii.comA

Is NeoGenomics Inc (NEO) a Bargain After 3.7% Drop? GF Value Says Undervalued

July 31, 2026 | gurufocus.com

Needham & Company LLC Forecasts Strong Price Appreciation for NeoGenomics (NASDAQ:NEO) Stock

July 31, 2026 | americanbankingnews.com

NeoGenomics (NASDAQ:NEO) Hits New 52-Week High After Better-Than-Expected Earnings

July 31, 2026 | americanbankingnews.com

Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), NeoGenomics (NEO)

July 30, 2026 | theglobeandmail.com

Why NeoGenomics (NEO) Stock Is Up Today

July 30, 2026 | finance.yahoo.com

NeoGenomics (NASDAQ:NEO) Reaches New 12-Month High After Earnings Beat

July 30, 2026 | defenseworld.netD

NeoGenomics Q2 Earnings, Revenue Rise; Ups Guidance

July 29, 2026 | finance.yahoo.com

NeoGenomics stock jumps 15% after beat and raise

July 29, 2026 | seekingalpha.com

NeoGenomics (NASDAQ:NEO) Hits New 1-Year High After Better-Than-Expected Earnings

July 29, 2026 | marketbeat.com

NeoGenomics, Inc. (NEO) Q2 2026 Earnings Call Transcript

July 29, 2026 | seekingalpha.com

NeoGenomics Inc (NEO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Raised ...

July 29, 2026 | finance.yahoo.com

NeoGenomics’s (NASDAQ:NEO) Q2 CY2026 beats on revenue

July 29, 2026 | msn.com

NeoGenomics anticipates $802M-$806M 2026 revenue as it targets mid-20% NGS growth and adjusts pharma expectations

July 29, 2026 | seekingalpha.com

NeoGenomics (NASDAQ:NEO) Given New $19.00 Price Target at Needham & Company LLC

July 29, 2026 | marketbeat.com

Gamco Investors INC. ET AL Boosts Stock Holdings in NeoGenomics, Inc. $NEO

July 29, 2026 | marketbeat.com

NeoGenomics, Inc. 2026 Q2 - Results - Earnings Call Presentation

July 28, 2026 | seekingalpha.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

AURA, BKY, NEO, and AREC Company Descriptions

American Resources NASDAQ:AREC

$2.04 +0.01 (+0.25%)

As of 01:41 PM Eastern

American Resources Corporation, together with its subsidiaries, extracts, processes, transports, and sells metallurgical coal to the steel and industrial industries. It supplies raw materials; and sells coal used in pulverized coal injections. The company was founded in 2006 and is headquartered in Fishers, Indiana.

Aura Biosciences NASDAQ:AURA

$7.20 +0.16 (+2.27%)

As of 01:41 PM Eastern

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

NeoGenomics NASDAQ:NEO

$16.08 +0.24 (+1.49%)

As of 01:41 PM Eastern

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AURA, BKY, NEO, and AREC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AURA, BKY, NEO, and AREC Earnings

Compare Dividends

Latest NEO, AURA, AREC, and NCCL Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AURA, BKY, NEO, and AREC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AURA, BKY, NEO, and AREC Company Descriptions

American Resources NASDAQ:AREC

Aura Biosciences NASDAQ:AURA

NeoGenomics NASDAQ:NEO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest AURA, BKY, NEO, and AREC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest AURA, BKY, NEO, and AREC Earnings

Compare Dividends

Latest NEO, AURA, AREC, and NCCL Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

AURA, BKY, NEO, and AREC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

AURA, BKY, NEO, and AREC Company Descriptions

American Resources NASDAQ:AREC

Aura Biosciences NASDAQ:AURA

NeoGenomics NASDAQ:NEO

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools